danazol has been researched along with Angioedema, Hereditary in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 13 (23.21) | 29.6817 |
2010's | 31 (55.36) | 24.3611 |
2020's | 12 (21.43) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Kan, H; Wang, X; Zhi, Y | 1 |
Beard, N; Frese, M; Katelaris, C; Mere, P; Mills, K; Smertina, E | 1 |
Xu, Y; Zhi, Y | 1 |
Marcílio Santos, G; Oliveira Dos Santos, F; Pimenta E Silva, LM; Rodrigues de Oliveira, F; Wolff Dick, JMJ | 1 |
Boccon-Gibod, I; Bouillet, L; Fain, O; Gobert, D; Launay, D; Trumbic, B | 1 |
Alachkar, H; Anantharachagan, A; Arkwright, PD; Bernatoniene, J; Bhole, M; Brown, L; Buckland, M; Burns, S; Chopra, C; Coulter, T; Darroch, J; Drewe, E; Edmonds, J; Ekbote, A; El-Shanawany, T; Elkhalifa, S; Garcez, T; Goddard, S; Grosse-Kreul, D; Gurugama, P; Hackett, S; Hague, R; Herriot, R; Herwadkar, A; Hughes, SM; Jain, R; Jones, L; Kham Murng, SH; Kiani-Alikhan, S; Lear, S; Manson, A; McDermott, E; Noorani, S; Price, A; Redenbaugh, V; Richter, A; Riordan, A; Sargur, R; Shackley, F; Springett, D; Steele, C; Stichbury, J; Stroud, C; Symons, C; Tarzi, MD; Thomas, M; Vijayadurai, P; Worth, A; Yong, PFK | 1 |
Busa, A; Cicardi, M; Donati, G; Ghezzi, M; Ranìa, V; Santicchia, I; Sparaco, A; Vacchini, R; Zanichelli, A | 1 |
Liu, S; Wang, X; Xu, Q; Xu, Y; Zhi, Y | 1 |
Banerji, A; Gower, R; Riedl, MA | 1 |
Akita, T; Fukunaga, A; Hide, M; Honda, D; Horiuchi, T; Iwamoto, K; Maehara, J; Ohsawa, I; Tanaka, A; Yamamoto, B; Yamashita, K | 1 |
Cao, Y; Liu, S; Zhi, Y | 1 |
Boğatekin, G; Bulut, G; Demir, S; Gelincik, A; Kuman Tunçel, O; Mete Gökmen, N; Mungan, D; Tunakan Dalgıç, C | 1 |
Farkas, H; Kőhalmi, KV; Luczay, A; Varga, L; Veszeli, N | 1 |
Andresen, I; Botha, J; Graif, Y; Kivity, S; Reshef, A; Toubi, E | 1 |
Hur, GY; Jung, JW; Kang, HR; Kim, CW; Kim, JH; Kim, S; Kim, SH; Koh, YI; Kwon, HS; Kwon, YE; Lee, JM; Lee, YW; Min, KU; Park, CS; Park, HJ; Park, HK; Park, JW; Suh, DI; Wickner, P; Yang, MS; Ye, YM | 1 |
Betschel, S; Fu, L; Kanani, A; Lacuesta, G; Waserman, S | 1 |
Chamaraux-Tran, TN; Goetz, J; Goichot, B; Levy, F; Steib, A; Zappaterra, M | 1 |
Bygum, A | 1 |
Csuka, D; Farkas, H; Kőszegi, L; Temesszentandrási, G; Tóth, F; Varga, L; Veszeli, N | 1 |
Berkel, AE; Bouman, DE; Klaase, JM; Schaafsma, MR; Verhoef, C | 1 |
Farmaki, E; Germenis, AE; Koutsostathis, N; Psarros, F; Speletas, MG | 1 |
Farkas, H; Kohalmi, KV; Varga, L; Veszeli, N; Zotter, Z | 1 |
Csuka, D; Farkas, H; Varga, L; Veszeli, N; Zotter, Z | 1 |
Riedl, MA | 1 |
Hisada, A; Honda, D; Inoshita, H; Mano, S; Nagamachi, S; Ohsawa, I; Shimamoto, M; Tomino, Y | 1 |
Bork, K; Bowen, T; Boysen, H; Craig, T; Farkas, H; Grumach, A; Katelaris, CH; Lockey, R; Longhurst, H; Lumry, W; Magerl, M; Martinez-Saguer, I; Maurer, M; Nast, A; Pawankar, R; Pürsün, EA; Ritchie, B; Zuraw, B | 1 |
Benedek, S; Csuka, D; Farkas, H; Imreh, É; Kőhalmi, KV; Varga, L; Veszeli, N; Zotter, Z | 1 |
Banerji, A; Bernstein, JA; Busse, P; Christiansen, S; Craig, T; Davis-Lorton, M; Frank, MM; Li, HH; Lumry, WR; Riedl, M; Zuraw, B | 1 |
Birjmohun, RS; Dallinga-Thie, GM; Hofstra, JJ; Kastelein, JJ; Kees Hovingh, G; Levi, M; Meijers, JC; Stroes, ES | 1 |
Chinniah, N; Katelaris, CH | 1 |
Bork, K; Hardt, J; Staubach, P; Witzke, G; Wulff, K | 1 |
Aygören-Pürsün, E; Heller, C; Klingebiel, T; Kreuz, W; Martinez-Saguer, I; Rusicke, E | 1 |
Bork, K | 2 |
Weis, M | 1 |
Csuka, D; Czaller, I; Farkas, H; Füst, G; Harmat, G; Jakab, L; Karádi, I; Prohászka, Z; Széplaki, G; Valentin, S; Varga, L; Vas, A; Visy, B | 1 |
Craig, TJ; Lunn, ML; Santos, CB | 1 |
Maskatia, ZK; Orson, FM | 1 |
Csuka, D; Czaller, I; Farkas, H; Füst, G; Tóth, F; Visy, B | 1 |
Baldoni, M; Carini, F; Leonida, A; Martini, M; Mingardi, M; Monguzzi, R; Morcavallo, PS; Rossi, G | 1 |
Bork, K; Csuka, D; Farkas, H; Füst, G; Varga, L | 1 |
Johnston, DT | 1 |
Csuka, D; Farkas, H; Füst, G; Varga, L | 1 |
Hide, M; Ikezawa, Z; Iwamoto, K; Mihara, S | 1 |
Parish, LC | 1 |
Hermans, C; Lambert, C; Vander Vorst, S | 1 |
Chung, JY; Kim, M | 1 |
Jariwala, SP; Rosenstreich, D; Shum, M | 1 |
Abuzakouk, M; Ishtiaq, J; Thoufeeq, MH | 1 |
Claude, O; Heusse, JL; Lantieri, L | 1 |
Härle, P; Kuklinek, P; Lokaj, J; Schölmerich, J; Straub, RH; Thon, V | 1 |
Farkas, H; Füst, G; Karádi, I; Prohászka, Z; Szegedi, R; Széplaki, G; Széplaki, Z; Varga, L | 1 |
Bernstein, IL | 1 |
Zuraw, BL | 1 |
Banerji, A; Sheffer, AL; Sloane, DE | 1 |
Bork, K; Bygum, A; Hardt, J | 1 |
10 review(s) available for danazol and Angioedema, Hereditary
Article | Year |
---|---|
Interventions for the long-term prevention of hereditary angioedema attacks.
Topics: Administration, Intravenous; Adult; Angioedemas, Hereditary; Child; Complement C1 Inhibitor Protein; Danazol; Female; Humans; Male; Quality of Life; Treatment Outcome | 2022 |
[Hereditary angioedema and its new treatments: An update].
Topics: Angioedema; Angioedemas, Hereditary; Bradykinin; Danazol; Humans; Quality of Life | 2023 |
Critical appraisal of androgen use in hereditary angioedema: a systematic review.
Topics: Androgens; Angioedemas, Hereditary; Animals; Danazol; Drug Dosage Calculations; Female; Humans; Lipid Metabolism; Menstruation Disturbances; Obesity; Risk Assessment; Stanozolol; Time Factors; Virilism | 2015 |
Clinical review of hereditary angioedema: diagnosis and management.
Topics: Adolescent; Adult; Angioedemas, Hereditary; Bradykinin; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Emergencies; Estrogen Antagonists; Humans | 2009 |
Hereditary angioedema in oral surgery: overview of the clinical picture and report of a case.
Topics: Adult; Alveolar Bone Loss; Angioedemas, Hereditary; Chronic Periodontitis; Complement C1 Inhibitor Protein; Danazol; Dental Care for Chronically Ill; Edema; Estrogen Antagonists; Female; Furcation Defects; Humans; Tooth Extraction; Tooth Mobility | 2010 |
Diagnosis and management of hereditary angioedema.
Topics: Adult; Algorithms; Angioedemas, Hereditary; Bradykinin; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Complement C4; Danazol; Diagnosis, Differential; Estrogen Antagonists; Female; Humans; Male; Risk Factors; Young Adult | 2011 |
Hereditary angioedema: diagnosis and management-a perspective for the dermatologist.
Topics: Adolescent; Adult; Androgens; Angioedemas, Hereditary; Antifibrinolytic Agents; Complement C1 Inhibitor Protein; Danazol; Humans | 2011 |
Current management options for hereditary angioedema.
Topics: Angioedemas, Hereditary; Bradykinin; Complement C1 Inhibitor Protein; Danazol; Disease Management; Humans; Oxandrolone; Peptides; Plasma; Recombinant Proteins; Stanozolol | 2012 |
Hereditary angioedema: a current state-of-the-art review, II: historical perspective of non-histamine-induced angioedema.
Topics: Adrenergic beta-Antagonists; Angioedemas, Hereditary; Animals; Bradykinin; Clinical Trials as Topic; Complement C1 Inactivator Proteins; Complement C2; Danazol; Disease Models, Animal; Factor XIIa; Genetic Linkage; Humans; Kallikreins; Mice; Peptides; Research | 2008 |
Hereditary angioedema: a current state-of-the-art review, V: attenuated androgens for the treatment of hereditary angioedema.
Topics: Androgens; Angioedemas, Hereditary; Child; Clinical Trials as Topic; Danazol; Estrogen Antagonists; Female; Humans; Male; Oxymetholone; Stanozolol | 2008 |
3 trial(s) available for danazol and Angioedema, Hereditary
Article | Year |
---|---|
Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
Topics: Adult; Angioedemas, Hereditary; Apolipoprotein A-I; Atherosclerosis; Blood Coagulation; Carotid Arteries; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cross-Over Studies; Cross-Sectional Studies; Danazol; Disease Progression; Female; Humans; Lipoproteins; Male; Middle Aged; Surveys and Questionnaires; Testosterone Congeners; Time Factors; Triglycerides; Tunica Intima | 2008 |
C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.
Topics: Adult; Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Complement Inactivating Agents; Danazol; Drug Resistance; Estrogen Antagonists; Female; Humans; Male; Middle Aged; Treatment Outcome | 2009 |
Long-term danazol prophylaxis does not lead to increased carotid intima-media thickness in hereditary angioedema patients.
Topics: Adolescent; Adult; Aged; Angioedemas, Hereditary; Carotid Arteries; Carotid Artery Diseases; Cholesterol, HDL; Cholesterol, LDL; Danazol; Estrogen Antagonists; Female; Humans; Male; Middle Aged; Prevalence; Risk Factors; Tunica Intima; Tunica Media; Ultrasonography | 2008 |
43 other study(ies) available for danazol and Angioedema, Hereditary
Article | Year |
---|---|
Gut microbiome alterations in hereditary angioedema.
Topics: Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Dysbiosis; Family; Gastrointestinal Microbiome; Humans; Tranexamic Acid | 2022 |
Long-term prophylaxis of hereditary angioedema with danazol.
Topics: Angioedemas, Hereditary; Danazol; Humans | 2022 |
[Hereditary bradykinin angioedema. Case report].
Topics: Adult; Angioedemas, Hereditary; Bradykinin; Danazol; Female; Humans; Quality of Life | 2023 |
A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom.
Topics: Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Female; Humans; Male; Surveys and Questionnaires; United Kingdom | 2023 |
Short-term prophylaxis in patients with angioedema due to C1-inhibitor deficiency undergoing dental procedures: An observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedema; Angioedemas, Hereditary; Child; Complement C1 Inhibitor Protein; Danazol; Dental Prophylaxis; Female; Humans; Italy; Male; Middle Aged; Treatment Outcome; Young Adult | 2020 |
Current status of the management of hereditary angioedema in China: a patient-based, cross-sectional survey.
Topics: Androgen Antagonists; Angioedemas, Hereditary; Blood Component Transfusion; China; Cross-Sectional Studies; Danazol; Health Care Surveys; Humans; Internet; Laryngeal Edema; Medication Adherence; Plasma | 2020 |
Current medical management of hereditary angioedema: Follow-up survey of US physicians.
Topics: Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Emergency Service, Hospital; Health Care Surveys; Hospitalization; Humans; Patient Satisfaction; Physicians; Practice Patterns, Physicians'; United States | 2021 |
The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey.
Topics: Adolescent; Adult; Aged; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Child; Child, Preschool; Complement C1 Inhibitor Protein; Complement Inactivating Agents; Danazol; Estrogen Antagonists; Female; Hospitalization; Humans; Japan; Male; Middle Aged; Patient Reported Outcome Measures; Steroids; Surveys and Questionnaires; Tranexamic Acid; Treatment Outcome; Young Adult | 2021 |
Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema.
Topics: Abdominal Pain; Acute Pain; Adolescent; Adult; Aged; Angioedemas, Hereditary; Child; China; Danazol; Delayed Diagnosis; Diagnosis, Differential; Female; Humans; Male; Middle Aged; Pain Measurement; Predictive Value of Tests; Recurrence; Treatment Outcome; Unnecessary Procedures; Young Adult | 2021 |
Psychiatric and Clinical Characteristics of Hereditary Angioedema Patients Who Experienced Attacks During COVID-19.
Topics: Adult; Angioedemas, Hereditary; Anxiety; COVID-19; Danazol; Female; Humans; Male; Middle Aged; SARS-CoV-2; Tranexamic Acid; Turkey | 2021 |
[Effect of danazol treatment on growth in pediatric patients with hereditary angioedema due to C1-inhibitor deficiency].
Topics: Adolescent; Angioedemas, Hereditary; Autoimmune Lymphoproliferative Syndrome; Child; Complement C1 Inhibitor Protein; Danazol; Estrogen Antagonists; Female; Growth Disorders; Humans; Male; Retrospective Studies; Risk Factors | 2017 |
Icatibant Outcome Survey in Patients with Hereditary Angioedema: Experience in Israel Compared with Other Countries.
Topics: Adult; Aged; Aged, 80 and over; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Danazol; Delayed Diagnosis; Female; Follow-Up Studies; Humans; Israel; Male; Middle Aged; Prospective Studies; Registries; Self Administration; Severity of Illness Index; Surveys and Questionnaires; Time Factors; Treatment Outcome; Young Adult | 2018 |
Clinical Features of Hereditary Angioedema in Korean Patients: A Nationwide Multicenter Study.
Topics: Adult; Angioedemas, Hereditary; Danazol; Delayed Diagnosis; Female; Humans; Male; Middle Aged; Republic of Korea; Retrospective Studies | 2018 |
Canadian physician survey on the medical management of hereditary angioedema.
Topics: Angioedemas, Hereditary; Canada; Complement C1 Inhibitor Protein; Danazol; Emergency Service, Hospital; Hospitalization; Humans; Patient Satisfaction; Practice Guidelines as Topic; Practice Patterns, Physicians'; Surveys and Questionnaires | 2018 |
Cardiac surgery and C1-inhibitor deficiency.
Topics: Aged, 80 and over; Amines; Analgesics; Anesthesia; Angioedemas, Hereditary; Antifibrinolytic Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Complement C1 Inhibitor Protein; Complement Inactivating Agents; Cyclohexanecarboxylic Acids; Danazol; Estrogen Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Histamine H1 Antagonists; Humans; Hydroxyzine; Preoperative Care; Tranexamic Acid | 2014 |
Hereditary angioedema - consequences of a new treatment paradigm in Denmark.
Topics: Activities of Daily Living; Administration, Cutaneous; Adult; Aged; Angioedemas, Hereditary; Bradykinin; Complement C1 Inhibitor Protein; Cost of Illness; Danazol; Denmark; Dermatologic Agents; Disease Progression; Drug Administration Schedule; Female; Home Care Services; Hospitalization; Humans; Male; Middle Aged; Motor Activity; Prospective Studies; Quality of Life; Registries; Time Factors; Tranexamic Acid; Treatment Outcome | 2014 |
Management of pregnancies in a hereditary angioedema patient after treatment with attenuated androgens since childhood.
Topics: Adult; Angioedemas, Hereditary; Antifibrinolytic Agents; Complement C1 Inhibitor Protein; Danazol; Estrogen Antagonists; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Tranexamic Acid | 2015 |
Hepatocellular carcinoma after danazol treatment for hereditary angio-oedema.
Topics: Aged; Angioedemas, Hereditary; Carcinoma, Hepatocellular; Danazol; Estrogen Antagonists; Female; Humans; Liver Neoplasms | 2014 |
Hereditary angioedema in Greece: the first results of the greek hereditary angioedema registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Child; Child, Preschool; Danazol; Estrogen Antagonists; Female; Follow-Up Studies; Greece; Humans; Male; Middle Aged; Quality of Life; Registries; Surveys and Questionnaires; Young Adult | 2014 |
Successful prophylaxis with recombinant human C1 inhibitor in a patient with hereditary angioedema.
Topics: Adult; Angioedemas, Hereditary; Bradykinin; Capillary Permeability; Child, Preschool; Complement Activation; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Female; Humans; Male; Middle Aged; Pedigree; Plasma; Practice Guidelines as Topic; Recombinant Proteins; Young Adult | 2015 |
Frequency of the virilising effects of attenuated androgens reported by women with hereditary angioedema.
Topics: Adult; Aged; Androgens; Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Data Collection; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Middle Aged; Retrospective Studies; Virilism; Young Adult | 2014 |
Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Topics: Adrenal Cortex Hormones; Adult; Androgens; Angioedemas, Hereditary; Antifibrinolytic Agents; Complement C1 Inhibitor Protein; Danazol; Delayed Diagnosis; Female; Genetic Testing; Health Knowledge, Attitudes, Practice; Histamine Antagonists; Humans; Japan; Male; Practice Patterns, Physicians'; Quality of Life; Surveys and Questionnaires; Tranexamic Acid | 2015 |
[WAO Guideline for the Management of Hereditary Angioedema].
Topics: Allergy and Immunology; Angioedemas, Hereditary; Bradykinin B2 Receptor Antagonists; Child; Child, Preschool; Complement C1 Inhibitor Protein; Danazol; Diagnosis, Differential; Evidence-Based Medicine; Female; Humans; International Cooperation; Kallikreins; Male; Patient Care Planning; Peptides; Practice Guidelines as Topic; Pregnancy; Recombinant Proteins; Social Support | 2015 |
The effect of long-term danazol treatment on haematological parameters in hereditary angioedema.
Topics: Adolescent; Adult; Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Female; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency.
Topics: Adolescent; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Antifibrinolytic Agents; Bradykinin; Child; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Genetic Testing; Humans; Patient Care Team; Patient Education as Topic; Peptides; Recombinant Proteins; Tranexamic Acid | 2016 |
Hereditary angioedema and pregnancy.
Topics: Adult; Angioedemas, Hereditary; Breast Feeding; Cohort Studies; Complement C1 Inhibitor Protein; Complement Inactivating Agents; Danazol; Estrogen Antagonists; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Retrospective Studies; Young Adult | 2009 |
Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy.
Topics: Adolescent; Adult; Age of Onset; Angioedemas, Hereditary; Child; Danazol; Factor XII; Female; Humans; Middle Aged; Mutation, Missense; Pedigree; Progesterone; Risk Factors; Severity of Illness Index; Surveys and Questionnaires; Tranexamic Acid; Young Adult | 2009 |
Hereditary angioedema with normal c1 inhibition.
Topics: Adrenal Cortex Hormones; Angioedemas, Hereditary; Angiotensin-Converting Enzyme Inhibitors; Complement C1 Inhibitor Protein; Danazol; Estrogen Antagonists; Estrogens; Factor XII; Female; Histamine Antagonists; Humans; Male; Mutation; Pedigree; Sex Factors | 2009 |
The effect of long-term danazol prophylaxis on liver function in hereditary angioedema-a longitudinal study.
Topics: Angioedemas, Hereditary; Autoimmune Lymphoproliferative Syndrome; Complement C1 Inactivator Proteins; Complement C1 Inhibitor Protein; Danazol; Humans; Liver Diseases; Liver Function Tests; Longitudinal Studies | 2010 |
Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?
Topics: Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Complement C4; Danazol; Diagnosis, Differential; Europe; Humans; Practice Guidelines as Topic; Surveys and Questionnaires; United States | 2010 |
Delayed diagnosis of hereditary angioedema.
Topics: Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Delayed Diagnosis; Estrogen Antagonists; Humans; Male; Middle Aged | 2010 |
The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey.
Topics: Abortion, Induced; Abortion, Spontaneous; Adolescent; Adult; Angioedemas, Hereditary; Antifibrinolytic Agents; Complement C1 Inhibitor Protein; Danazol; Delivery, Obstetric; Female; Humans; Hungary; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Retrospective Studies; Young Adult | 2010 |
Long-term efficacy of danazol treatment in hereditary angioedema.
Topics: Adolescent; Adult; Analysis of Variance; Androgens; Angioedemas, Hereditary; Danazol; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Germany; Humans; Hungary; Male; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2011 |
Parameters of the classical complement pathway predict disease severity in hereditary angioedema.
Topics: Adolescent; Adult; Aged; Angioedemas, Hereditary; Child; Child, Preschool; Complement Pathway, Classical; Danazol; Estrogen Antagonists; Female; Genetic Markers; Humans; Male; Middle Aged; Young Adult | 2011 |
[National prevalence survey of hereditary angioedema in Japan].
Topics: Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Humans; Japan; Prevalence; Tranexamic Acid | 2011 |
Successful management of hereditary angioedema during tonsillectomy: a case report.
Topics: Adult; Angioedemas, Hereditary; Complement C1 Inhibitor Protein; Danazol; Edema; Female; Humans; Tonsillectomy; Tonsillitis; Tranexamic Acid | 2012 |
Migraine-like headache in a patient with complement 1 inhibitor deficient hereditary angioedema.
Topics: Adult; Angioedemas, Hereditary; Brain; Complement C1 Inhibitor Protein; Danazol; Estrogen Antagonists; Humans; Magnetic Resonance Angiography; Male; Migraine Disorders; Piperidines; Radionuclide Imaging; Tryptamines; Vasoconstrictor Agents | 2012 |
Successful C1 inhibitor prophylaxis during zenker diverticulum repair in a patient with hereditary angioedema.
Topics: Aged; Angioedemas, Hereditary; Child; Complement C1 Inhibitor Protein; Danazol; Female; Humans; Middle Aged; Perioperative Care; United States; Zenker Diverticulum | 2012 |
Danazol-Induced Hepatocellular Carcinoma in a Patient with Hereditary Angioedema.
Topics: Aged; Angioedemas, Hereditary; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Danazol; Estrogen Antagonists; Humans; Liver Neoplasms; Male; Prognosis; Tomography, X-Ray Computed | 2012 |
[Can one propose aesthetic surgery to one male or female patient with an hereditary angio-oedema?].
Topics: Adult; Angioedemas, Hereditary; Breast; Danazol; Estrogen Antagonists; Female; Humans; Intubation, Intratracheal; Mammaplasty | 2008 |
Lack of dehydroepiandrosterone in type I and II hereditary angioedema and role of danazol in steroid hormone conversion.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Androstenedione; Angioedemas, Hereditary; Child; Danazol; Dehydroepiandrosterone; Estradiol; Female; Humans; Hydrocortisone; Male; Middle Aged; Testosterone | 2007 |
Hereditary angiodema: a current state-of-the-art review, IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?
Topics: Aminocaproic Acid; Anabolic Agents; Androgens; Angioedemas, Hereditary; Antifibrinolytic Agents; Blood Transfusion; Clinical Trials as Topic; Complement C1 Inhibitor Protein; Danazol; Estrogen Antagonists; Estrogen Replacement Therapy; Humans; Kallikreins; Peptides | 2008 |
Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients.
Topics: Adult; Angioedemas, Hereditary; Danazol; Dose-Response Relationship, Immunologic; Estrogen Antagonists; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Severity of Illness Index | 2008 |